Physician profile
Diane Thomas
NPI 1992953152
$735.32
in general payments reported to CMS, 2019-2025
9 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.91 · 2022: $24.10 · 2023: $68.01 · 2024: $352 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $267.07 | 2023-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $134.01 | 2021-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $118.19 | 2023-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Novo Nordisk INC | $69.25 | 2021-2025 | Ozempic |
| Pfizer INC. | $53.50 | 2023-2024 | |
| Seqirus USA INC | $24.72 | 2024 | Fluad, Flucelvax |
| Edwards Lifesciences Corporation | $24.10 | 2022 | |
| Exact Sciences Corporation | $23.50 | 2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $20.98 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.